CINF vs STRO
Cincinnati Financial Corporation (CINF) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CINF and STRO stock pages for the full models.
Not investment advice.